Leflunomide - sanofi-aventis
At a glance
- Drug Originator sanofi-aventis
- Drug Licenced by ESTEVE; Pfizer
- Drug Class Antineoplastics; Disease-modifying antirheumatics; Isoxazoles; Small molecules
- Mechanism of Action Dihydroorotate dehydrogenase inhibitors; Dihydropteroate synthase inhibitors; Epidermal growth factor receptor antagonists; Immunosuppressants; Protein tyrosine kinase inhibitors
- USA Patent Applicants SANOFI AVENTIS US
- USA Patents 3
- NDAs 1
- Patent Applications 4,460
Table of Contents

Disclaimer